Total thyroidectomy vs thyroid lobectomy for localized medullary thyroid cancer in adults: A propensity-matched survival analysis
Weili Liang,Jinyuan Shi,Hui Zhang,Guixu Lv,Tiantian Wang,Yong Wang,Bin Lv,Luchuan Li,Qingdong Zeng,Lei Sheng,Weili Liang,Jinyuan Shi,Hui Zhang,Guixu Lv,Tiantian Wang,Yong Wang,Bin Lv,Luchuan Li,Qingdong Zeng,Lei Sheng
DOI: https://doi.org/10.1016/j.surg.2022.06.023
IF: 4.348
2022-11-01
Surgery
Abstract:BackgroundThis study aimed to clarify whether the extent of thyroidectomy (total thyroidectomy vs thyroid lobectomy) influences survival in adults with localized medullary thyroid cancer.MethodsPatients with localized medullary thyroid cancer were identified using the Surveillance, Epidemiology, and End Results database (2000–2018). An independent cohort of patients with localized medullary thyroid cancer were retrospectively reviewed from three medical centers in China from 2010 to 2020. The patients were grouped by the extent of surgery (total thyroidectomy vs thyroid lobectomy). Primary end points were overall survival and disease-specific survival.ResultsFrom 1,686 patients with medullary thyroid cancer identified in SEER, 1,122 patients met inclusion for matching, with a median follow-up of 99 months. After propensity score matching, 122 patients underwent a total thyroidectomy and 122 patients underwent a thyroid lobectomy. The 10-year overall survival was 85.2% (77.9%–90.7%) and 83.1% (75.5%–90.7%) in total thyroidectomy group and in thyroid lobectomy group, respectively. The 10-year disease-specific survival was 100% and 96.8% (93.1%–100%) in total thyroidectomy group and in thyroid lobectomy group, respectively. There was no statistically significant difference in overall survival or disease-specific survival in patients with localized medullary thyroid cancer undergoing total thyroidectomy or thyroid lobectomy (hazard ratio = 0.83, 95% confidence interval 0.44–1.57, P = .57 and hazard ratio = 0.49, 95% confidence interval 0.10–2.41, P = .39, respectively). Forty-seven patients with localized medullary thyroid cancer were identified in an independent Chinese cohort (n = 29 in total thyroidectomy group vs n = 18 in thyroid lobectomy group). After a median follow-up of 47 months, there was no mortality observed in either group.ConclusionThis study suggests that the extent of thyroidectomy does not influence survival for patients with early-stage localized medullary thyroid cancer and that thyroid lobectomy might be adequate in this patient population.
surgery